FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely oncology and can be used for cancer immunorehabilitation. According to the invention, the method implies the hypodermic implantation of porous titanic carrier incubators with the vaccine deposited with their pores. The porous titanic carrier incubators are used as said carriers, while the vaccine is presented with proper lymphokine-activated killers modified by the electromagnetic field.
EFFECT: invention allows lowering metastatic activity of a tumour owing to creation in an organism of functionally active immunocompetent cell depots ensuring activation of various immunity links within constitutive synthesis of cytokines.
2 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING DEPOSITED LYMPHOKINE-ACTIVATED KILLER CELLS | 2009 |
|
RU2400238C1 |
| BIODEGRADABLE IMPLANT FOR LOCAL IMMUNOTHERAPY OF CANCER PATIENTS | 2021 |
|
RU2780932C1 |
| BIODEGRADABLE METAL IMPLANT FOR LOCAL IMMUNOTHERAPY OF PATIENTS WITH SOLID TUMORS | 2021 |
|
RU2780927C1 |
| TITANIUM IMPLANT WITH THE FUNCTION OF LOCAL IMMUNOTHERAPY FOR OSTEORECONSTRUCTIVE SURGERY AND PREVENTION OF LOCAL RECURRENCE OF ONCOLOGICAL DISEASE AND METHOD FOR ITS MANUFACTURE | 2021 |
|
RU2779367C1 |
| METHOD FOR TREATING ONCOLOGIC PATIENTS | 2004 |
|
RU2285548C2 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| METHOD FOR PRODUCING ACTIVATED LEUKOCYTES FOR ADJUVANT ADOPTIVE IMMUNOTHERAPY OF MALIGNANT GROWTHS | 2009 |
|
RU2414915C2 |
| METHOD OF CYTOGENETIC ACTIVATION OF HUMAN LYMPHOCYTES | 2015 |
|
RU2603079C2 |
| METHOD FOR CANCER ADOPTIVE IMMUNOTHERAPY | 2016 |
|
RU2613884C1 |
| COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
